Stem Cell Cryopreservation Global Market Report 2025

The stem cell cryopreservation market size has grown rapidly in recent years. It will grow from $3.48 billion in 2024 to $4.17 billion in 2025 at a compound annual growth rate (CAGR) of 19.9%. Growth during the historic period can be attributed to increasing awareness of stem cell therapies, greater adoption of regenerative medicine, rising demand for cord blood banking, expansion of healthcare infrastructure, and growing investments in biotechnology.

The stem cell cryopreservation market size is expected to see rapid growth in the next few years. It will grow to $8.52 billion in 2029 at a compound annual growth rate (CAGR) of 19.6%. Growth in the forecast period can be attributed to expanding government initiatives supporting stem cell research, the rising prevalence of chronic diseases, increasing funding for regenerative medicine, growth in private stem cell banking services, and the expanding clinical applications of stem cells. Major trends expected in the forecast period include technological advancements in cryopreservation, innovations in cell storage solutions, developments in automated freezing systems, progress in stem cell therapy research, and advancements in personalized medicine applications.

The rising prevalence of degenerative diseases is expected to drive the growth of the stem cell cryopreservation market. Degenerative diseases, which involve progressive deterioration of tissues or organs, are increasingly common due to the aging global population. Stem cell cryopreservation allows for the long-term storage of viable stem cells, providing a ready source for regenerative therapies aimed at repairing or replacing damaged tissues. For example, according to the Alzheimer's Association, approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia in 2023, with projections reaching 13.8 million by 2060. This rising burden of degenerative diseases is creating strong demand for regenerative therapies supported by stem cell cryopreservation.

Companies in the market are focusing on innovative freezing solutions to enhance cell viability and support scalable therapy development. Advanced cryopreservation media protect stem cells during freezing and thawing, while automation-friendly freezing systems enable reproducible, large-scale processing. In April 2024, Pluristyx, Inc., a US-based biotechnology company, launched PluriFreeze, a synthetic, animal-origin-free cryopreservation medium designed for pluripotent and sensitive stem cells. The solution improves post-thaw viability and functional integrity, integrates with automated workflows, and supports scalable clinical and research applications.

In April 2025, BioLife Solutions Inc., a US healthcare technology company, acquired a 90% stake in PanTHERA CryoSolutions Inc. for $21.53 million. This acquisition enhances BioLife’s technological capabilities in stem cell cryopreservation and expands its presence in advanced biobanking solutions, reinforcing the market’s capacity to support regenerative therapies for degenerative diseases.

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

North America was the largest region in the stem cell cryopreservation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in stem cell cryopreservation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the stem cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The stem cell cryopreservation market research report is one of a series of new reports that provides stem cell cryopreservation market statistics, including stem cell cryopreservation industry global market size, regional shares, competitors with a stem cell cryopreservation market share, detailed stem cell cryopreservation market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell cryopreservation industry. This stem cell cryopreservation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Stem cell cryopreservation refers to the process of storing stem cells at ultra-low temperatures to preserve their viability and biological functions for long-term use. This method enables stem cells to be safely maintained for future therapeutic applications, research purposes, or transplantation.

The main types of stem cell cryopreservation include embryonic stem cells, adult stem cells, and induced pluripotent stem cells. Embryonic stem cells are pluripotent cells derived from the inner cell mass of a blastocyst, with the ability to differentiate into any cell type in the body. They are used across various applications, including cell freezing media, equipment, and consumables, and serve a range of end users such as biopharmaceutical companies, research institutes, blood banks, and in vitro fertilization (IVF) clinics.

The stem cell cryopreservation market consists of revenues earned by entities by providing services such as collection and processing of stem cells, long-term storage and preservation, quality testing and viability assessment, regulatory compliance and documentation services, and insurance and risk management services. The market value includes the value of related goods sold by the service provider or included within the service offering. The stem cell cryopreservation market also includes sales of ultra-low-temperature storage equipment, rewarming devices, storage and retrieval systems, and ancillary support products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.